UVA Health neurologists are helping to improve the understanding and clinical care of Huntington's disease by contributing to a global observational study.
Research into neuron death in Alzheimer's disease at UVA Health has laid the groundwork for clinical studies aimed at improving patient prognosis.
A UVA Health researcher and colleagues have found that a new drug combination may lengthen survival in patients with advanced non-squamous NSCLC.
The new Focused Ultrasound Cancer Immunotherapy Center positions UVA Health as the worldwide leader in translational FUS immuno-oncology research.
A team of UVA Health researchers has found evidence that screening for STAT3 mutations will help to better classify and diagnose patients with LGL leukemia.